![]() Recommended phase 2 dose (RP2D) of VIP152 (BAY 1251152). ![]() AUC from time 0 to the last data point > LLOQ after multiple dosing of VIP152 (BAY1251152).Maximum observed drug concentration in measured matrix after multiple dose administration during a dosage interval (Cmax,md) of VIP152 (BAY1251152).AUC from time 0 to the last data point > Lower limit of quantitation (LLOQ) of VIP152 (BAY1251152).Area under the concentration versus time curve from zero to infinity after single (first) dose (AUC) of VIP152 (BAY1251152).Maximum observed drug concentration in measured matrix after single dose administration (Cmax) of VIP152 (BAY1251152).Incidence of DLT (Dose limit toxicity) of VIP152 (BAY1251152).Why Should I Register and Submit Results?.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |